SeaSpine Holdings Co. (NASDAQ:SPNE – Get Rating) – Equities researchers at Cantor Fitzgerald issued their FY2022 earnings estimates for SeaSpine in a research report issued to clients and investors on Tuesday, April 12th. Cantor Fitzgerald analyst R. Osborn forecasts that the medical equipment provider will post earnings of ($0.89) per share for the year. Cantor Fitzgerald currently has a “Overweight” rating on the stock.
SeaSpine (NASDAQ:SPNE – Get Rating) last posted its quarterly earnings results on Friday, March 11th. The medical equipment provider reported ($0.52) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.34) by ($0.18). SeaSpine had a negative net margin of 28.39% and a negative return on equity of 21.26%.
SPNE stock opened at $10.74 on Friday. The firm has a market cap of $395.12 million, a P/E ratio of -6.63 and a beta of 1.19. SeaSpine has a 12-month low of $10.66 and a 12-month high of $22.78. The stock’s 50 day simple moving average is $11.84 and its 200 day simple moving average is $13.16.
Institutional investors and hedge funds have recently modified their holdings of the company. HighTower Advisors LLC increased its holdings in shares of SeaSpine by 12.8% during the third quarter. HighTower Advisors LLC now owns 96,162 shares of the medical equipment provider’s stock valued at $1,511,000 after purchasing an additional 10,896 shares during the period. Rothschild & Co. Asset Management US Inc. increased its holdings in shares of SeaSpine by 16.3% during the third quarter. Rothschild & Co. Asset Management US Inc. now owns 74,368 shares of the medical equipment provider’s stock valued at $1,170,000 after purchasing an additional 10,423 shares during the period. MFA Wealth Advisors LLC bought a new position in SeaSpine during the third quarter valued at about $71,000. Moors & Cabot Inc. bought a new position in SeaSpine during the third quarter valued at about $4,874,000. Finally, BlackRock Inc. boosted its stake in SeaSpine by 0.5% during the third quarter. BlackRock Inc. now owns 2,415,642 shares of the medical equipment provider’s stock valued at $37,998,000 after buying an additional 13,132 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors.
About SeaSpine (Get Rating)
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine.
- Get a free copy of the StockNews.com research report on SeaSpine (SPNE)
- Array Technologies Stock Giving Another Ground Floor Entry
- UiPath Stock is Nearing Rock Bottom Down Here
- 3 Undervalued S&P 500 Stocks to Buy Now
- 3 Undervalued Easter Eggs to Watch For This Earnings Season
- Lululemon Rises On Wave Of Price Target Increases
Receive News & Ratings for SeaSpine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine and related companies with MarketBeat.com's FREE daily email newsletter.